Vor Biopharma Inc. (VOR)

Vor Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	31.72	28.87	21.49	11.75	4.22
Research & Development	94.32	64.55	47.53	31.62	6.2
Operating Expenses	126.04	93.42	69.02	43.37	10.42
Operating Income	-126.04	-93.42	-69.02	-43.37	-10.42
Interest Expense / Income	0	0	0	0	0.61
Other Expense / Income	-8.17	-1.32	-0.12	-0.03	-0.19
Pretax Income	-117.86	-92.09	-68.9	-43.34	-10.84
Net Income	-117.86	-92.09	-68.9	-43.34	-10.84
Preferred Dividends	0	0	1.23	5.93	1.77
Net Income Common	-117.86	-92.09	-70.13	-49.26	-12.61
Shares Outstanding (Basic)	67	40	33	0	2
Shares Outstanding (Diluted)	67	40	33	0	2
Shares Change	69.89%	18.30%	15548.00%	-86.33%	30.97%
EPS (Basic)	-1.75	-2.33	-2.10	-230.57	-8.07
EPS (Diluted)	-1.75	-2.33	-2.10	-230.57	-8.07
Free Cash Flow	-101.36	-93.61	-73.04	-40.45	-10.6
Free Cash Flow Per Share	-1.51	-2.37	-2.19	-189.34	-6.78
EBITDA	-109.64	-85.99	-64.45	-41.95	-10.14
Depreciation & Amortization	8.22	6.1	4.45	1.39	0.09
EBIT	-117.86	-92.09	-68.9	-43.34	-10.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).